Literature DB >> 17564862

Quality of life in children with epilepsy and cognitive impairment: a review and a pilot study.

Carmen Soria1, Sandra El Sabbagh, Sylvie Escolano, René Bobet, Christine Bulteau, Georges Dellatolas.   

Abstract

Various methods have recently been proposed to assess the physical, psychological or social dimensions of quality of life (QoL) in children with epilepsy (CwE) and their families. Some methods are based exclusively on parental report and others emphasize the importance of an interview with the patient himself. In children with epilepsy and severe cognitive deficit only parental report is possible in practice; however, some parental based methods to evaluate QoL in CwE have excluded children with cognitive deficit. The present pilot study explores which items are suitable for a parental-based QoL evaluation in CwE and special educational needs, and the most frequently reported parental concerns in this special population of children.

Entities:  

Mesh:

Year:  2007        PMID: 17564862     DOI: 10.1080/13638490601111129

Source DB:  PubMed          Journal:  Dev Neurorehabil        ISSN: 1751-8423            Impact factor:   2.308


  3 in total

1.  Development of later life spontaneous seizures in a rodent model of hypoxia-induced neonatal seizures.

Authors:  Sanjay N Rakhade; Peter M Klein; Thanthao Huynh; Cristina Hilario-Gomez; Bela Kosaras; Alexander Rotenberg; Frances E Jensen
Journal:  Epilepsia       Date:  2011-03-02       Impact factor: 5.864

2.  Effect of age on cognitive sequelae following early life seizures in rats.

Authors:  Havisha B Karnam; Qian Zhao; Tatiana Shatskikh; Gregory L Holmes
Journal:  Epilepsy Res       Date:  2009-04-22       Impact factor: 3.045

3.  Health-related quality of life in adults with epilepsy: the effect of age, age at onset and duration of epilepsy in a multicentre Italian study.

Authors:  Valeria Edefonti; Francesca Bravi; Katherine Turner; Ettore Beghi; Maria Paola Canevini; Monica Ferraroni; Ada Piazzini
Journal:  BMC Neurol       Date:  2011-03-10       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.